A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.

Clinically, oclacitinib delayed development of dermatitis at the site of allergen application. TEWL results were difficult to interpret and additional studies are required for clarification.